Co-head of Pharmaceuticals - Equity Research @ (June 2016 - October 2019)
Head of Discovery Research @ (March 2013 - July 2014)
Head of European Healthcare @ (March 2005 - July 2012)
Management consultant @ (January 2000 - January 2005)
University Lecturer @ Neural Systems Group, Newcastle University (January 1995 - January 1999)
Researcher in Computational Neuroscience and Systems Neuroscience @ University of Oxford, Department of Physiology (January 1991 - January 1995)
Jack Scannell Education
Oxford University
Doctor of Philosophy (Philosophy, Neuroscience)
1991-1995
Trinity College, Cambridge University
(Zoology)
1986-1989
Jack Scannell Skills
Molecular Biology
Equity Research
Financial Modeling
Network Pharmacology
Lifesciences
Data Analysis
Due Diligence
Biotechnology
Valuation
Computational Neuroscience
Bioinformatics
Systems Biology
Life Sciences
R&D
Equities
Drug Discovery
Jack Scannell Summary
Jack Scannell, based in Edinburgh, GB, is currently a Venture Director at Hiro Capital. Jack Scannell brings experience from previous roles at Etheros Pharmaceuticals, JW Scannell Analytics LTD, UBS and e-Therapeutics PLC. Jack Scannell holds a 1991 - 1995 Doctor of Philosophy in Philosophy, Neuroscience @ Oxford University. With a robust skill set that includes Molecular Biology, Equity Research, Financial Modeling, Network Pharmacology, Lifesciences and more. Jack Scannell has 1 emails on RocketReach.
Looking for a different Jack Scannell?
Find contact details for 700 million professionals.